Cigna Group (CI) Stock Price & Analysis

Cigna Group (CI) fell 1.31% to USD 282.52 as of September 8, 2026 at 05:11 UTC, according to Nexqual real-time market data.

CI last closed at USD 282.52; the session ranged USD 281.63–284.67 on volume of 1,106,053 shares. Market capitalization is —, with a 52-week range of USD 239.51–315.47 (NYQ). Source: Nexqual, September 8, 2026 at 05:11 UTC.

Key Statistics (as of September 8, 2026 at 05:11 UTC)

Technical Analysis (CI)

Nexqual's technical model rates CI "NEUTRAL" based on 3 bullish and 2 bearish signals across 128 daily candles, as of September 8, 2026 at 05:11 UTC.

From Cigna Group's Latest SEC 10-K Filing (filed 2026-02-26)

Key Strengths & Strategy (as disclosed to the SEC)

• Our formulary management   services support clients in establishing formularies that assist customers and physicians in choosing clinically appropriate, cost-effective drugs and prioritize access, safety and affordability. ▪ We administer specific formularies for our clients, including standard formularies developed by Express Scripts ® Pharmacy Benefit Services ("Express Scripts") and custom formularies in which we play a more limited role.
• Health System Services includes CuraScript SD by Evernorth ® , which is a specialty distributor of pharmaceuticals and medical supplies (including injectable and infusible pharmaceuticals and medications to treat specialty and rare or orphan diseases) directly to health care providers, including clinics and hospitals in the United States for office or clinic administration.
• We use these patents to protect our proprietary technological advances and to differentiate ourselves in the market.
• Our ability to deliver this broad array of health care services on either a standalone or combined basis between its two operating segments enables us to drive incremental growth.

Partnerships

• Through our clinical programs and partnership with EviCore, we guide care to the most appropriate settings, reducing unnecessary costs while preserving quality and service, and offer virtual care options, including MD Live, to improve convenience and access.

Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.

Peers & Related Stocks

Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 05:11 UTC. This page is informational and not investment advice.